Cargando…
Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems
Cystic fibrosis (CF) patients develop a severe form of the disease when the cystic fibrosis transmembrane conductance regulator (CFTR) gene is affected by nonsense mutations. Nonsense mutations are responsible for the presence of a premature termination codon (PTC) in the mRNA, creating a lack of fu...
Autores principales: | Pibiri, Ivana, Melfi, Raffaella, Tutone, Marco, Di Leonardo, Aldo, Pace, Andrea, Lentini, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504161/ https://www.ncbi.nlm.nih.gov/pubmed/32899265 http://dx.doi.org/10.3390/ijms21176420 |
Ejemplares similares
-
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
por: Campofelice, Ambra, et al.
Publicado: (2019) -
Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR
por: Carollo, Pietro Salvatore, et al.
Publicado: (2023) -
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression
por: Perriera, Riccardo, et al.
Publicado: (2023) -
Toward a Rationale for the PTC124 (Ataluren) Promoted
Readthrough of Premature Stop Codons: A Computational Approach and
GFP-Reporter Cell-Based Assay
por: Lentini, Laura, et al.
Publicado: (2014) -
Caffeine boosts Ataluren's readthrough activity
por: Lentini, Laura, et al.
Publicado: (2019)